Accelerated infusion rates of rituximab are well tolerated and safe in rheumatology practice: a single-centre experience

Biologics for rheumatoid arthritis: an overview of Cochrane reviews

(2017) Jasvinder A. Singh et al.   Sao Paulo Medical Journal

Updated consensus statement on the use of rituximab in patients with rheumatoid arthritis

(2011) M. H. Buch et al.   ANNALS OF THE RHEUMATIC DISEASES

Blood memory B cells are disturbed and predict the response to rituximab in patients with rheumatoid arthritis

(2011) Jérémie Sellam et al.   ARTHRITIS AND RHEUMATISM

Rapid infusion with rituximab: short term safety in systemic autoimmune diseases

(2011) Janni Lisander Larsen et al.   RHEUMATOLOGY INTERNATIONAL

A prospective study to evaluate the feasibility and economic benefits of rapid infusion rituximab at an Asian cancer center

(2010) Joen Chiang et al.   INTERNATIONAL JOURNAL OF HEMATOLOGY

Longterm Safety of Patients Receiving Rituximab in Rheumatoid Arthritis Clinical Trials

(2010) R. F. van VOLLENHOVEN et al.   JOURNAL OF RHEUMATOLOGY

A proposed EGFR inhibitor dermatologic adverse event-specific grading scale from the MASCC skin toxicity study group

(2010) Mario E. Lacouture et al.   SUPPORTIVE CARE IN CANCER

Review of the Safety and Feasibility of Rapid Infusion of Rituximab

(2010) Jill Atmar   Journal of Oncology Practice

Rapid infusion of rituximab over 60 min

(2009) Mark Tuthill et al.   EUROPEAN JOURNAL OF HAEMATOLOGY

Rapid Infusion Rituximab Changing Practice for Patient Care

(2009) Ali Al Zahrani et al.   JOURNAL OF ONCOLOGY PHARMACY PRACTICE